Prognostic Value of Interferon Gamma Release Assays in Predicting Active Tuberculosis Among Individuals With, or at Risk of, Latent Tuberculosis Infection
Condition(s):Tuberculosis; Latent TuberculosisLast Updated:October 1, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Tuberculosis; Latent TuberculosisLast Updated:October 1, 2020Completed
Condition(s):TuberculosisLast Updated:January 16, 2008Completed
Condition(s):Ewing’s Sarcoma; Osteosarcoma; Neuroblastoma; RhabdomyosarcomaLast Updated:December 17, 2019Terminated
Condition(s):Prostate CancerLast Updated:June 25, 2013Completed
Condition(s):Type 1 DiabetesLast Updated:March 17, 2015Completed
Condition(s):COVID-19Last Updated:May 15, 2020Completed
Condition(s):LymphomaLast Updated:October 17, 2013Completed
Condition(s):Hemophagocytic LymphohistiocytosesLast Updated:September 21, 2023Completed
Condition(s):Hemophagocytic LymphohistiocytosisLast Updated:March 17, 2020Completed
Condition(s):Hemophagocytic LymphohistiocytosisLast Updated:June 28, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.